Evidence map›Paper›PMID 23819887›Full record

ArticleBMC medical genomics2013

Compensating for literature annotation bias when predicting novel drug-disease relationships through Medical Subject Heading Over-representation Profile (MeSHOP) similarity.

Warren A Cheung, B F Francis Ouellette, Wyeth W Wasserman

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. MeSHDD: Literature-based drug-drug similarity for drug repositioning.Journal of the American Medical Informatics Association : JAMIA · 2017
    Article
  3. Article
  4. 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities.Database : the journal of biological databases and curation · 2016
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Warren A CheungCentre for Molecular Medicine and Therapeutics at Child and Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
B F Francis Ouellette
Wyeth W Wasserman
Child and Family Research Institute · CAUniversity of Toronto · CA

Funding

Computational Resources for the Compilation and Distribution of Transcription FacR01GM084875 · NIGMS · UNIVERSITY OF BRITISH COLUMBIA · PI WASSERMAN, WYETH W · 2010 to 2012
$1.0M
CIHRNIGMS NIH HHS R01 GM084875NIGMS NIH HHS R01GM084875
6 · The paper itself

Abstract

backgroundUsing annotations to the articles in MEDLINE®/PubMed®, over six thousand chemical compounds with pharmacological actions have been tracked since 1996. Medical Subject Heading Over-representation Profiles (MeSHOPs) quantitatively leverage the literature associated with biological entities such as diseases or drugs, providing the opportunity to reposition known compounds towards novel disease applications.

methodsA MeSHOP is constructed by counting the number of times each medical subject term is assigned to an entity-related research publication in the MEDLINE database and calculating the significance of the count by comparing against the count of the term in a background set of publications. Based on the expectation that drugs suitable for treatment of a disease (or disease symptom) will have similar annotation properties to the disease, we successfully predict drug-disease associations by comparing MeSHOPs of diseases and drugs.

resultsThe MeSHOP comparison approach delivers an 11% improvement over bibliometric baselines. However, novel drug-disease associations are observed to be biased towards drugs and diseases with more publications. To account for the annotation biases, a correction procedure is introduced and evaluated.

conclusionsBy explicitly accounting for the annotation bias, unexpectedly similar drug-disease pairs are highlighted as candidates for drug repositioning research. MeSHOPs are shown to provide a literature-supported perspective for discovery of new links between drugs and diseases based on pre-existing knowledge.

Indexed as

DiseaseDrug DesignDrug RepositioningMedical Subject HeadingsPeriodicals as TopicComputational BiologyDatabases, FactualHumansInformation Storage and RetrievalMEDLINEPharmaceutical PreparationsPharmaceutical Preparations

Identifiers

PMID23819887
PMCPMC3654871
OpenAlexW2022692405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.